カテゴリー： QYResearch, 世界

世界のがんmTOR阻害剤市場 2019年

【英語タイトル】Global Cancer mTOR Inhibitors Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X04992）・商品コード：DATA909X04992
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、がんmTOR阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アフィニトール/ Votubia、Afinitor Disperz andndash; まれな小児脳腫瘍のmTOR阻害剤、トリセル（テムシロリムス）、エバーターアンドンダッシュに、用途別には、乳がん、血液悪性腫瘍、神経内分泌腫瘍、肝細胞癌、膠芽腫にセグメント区分し、がんmTOR阻害剤の世界市場を分析しました。


・エグゼクティブ・サマリー
・がんmTOR阻害剤の世界市場概要
・がんmTOR阻害剤の製造コスト構成分析
・がんmTOR阻害剤の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・がんmTOR阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・がんmTOR阻害剤のセグメント分析（種類別）
（アフィニトール/ Votubia、Afinitor Disperz andndash; まれな小児脳腫瘍のmTOR阻害剤、トリセル（テムシロリムス）、エバーターアンドンダッシュ）
・がんmTOR阻害剤のセグメント分析（用途別）
（乳がん、血液悪性腫瘍、神経内分泌腫瘍、肝細胞癌、膠芽腫）
・がんmTOR阻害剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Abraxis BioScience、Adimab、Celgene Corporation、Celator Pharmaceuticals、Eli Lilly、Exelixis、GlaxoSmithKline、HEC Pharm、Intellikine、Novartis、Oneness Biotech、PIQUR Therapeutics、Semafore Pharmaceuticals、Takeda、Wyeth、）
・がんmTOR阻害剤の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Cancer mTOR Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cancer mTOR Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer mTOR Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer mTOR Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer mTOR Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abraxis BioScience
Adimab
Celgene Corporation
Celator Pharmaceuticals
Eli Lilly
Exelixis
GlaxoSmithKline
HEC Pharm
Intellikine
Novartis
Oneness Biotech
PIQUR Therapeutics
Semafore Pharmaceuticals
Takeda
Wyeth

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Afinitor/Votubia
Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
Torisel (Temsirolimus)
Evertor andndash

Segment by Application
Breast Cancer
Hematological Malignancy
Neuroendocrine Tumors
Hepatocellular Carcinoma
Glioblastoma

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Cancer mTOR Inhibitors
1.1 Definition of Cancer mTOR Inhibitors
1.2 Cancer mTOR Inhibitors Segment by Type
1.2.1 Global Cancer mTOR Inhibitors Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Afinitor/Votubia
1.2.3 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
1.2.4 Torisel (Temsirolimus)
1.2.5 Evertor andndash
1.3 Cancer mTOR Inhibitors Segment by Applications
1.3.1 Global Cancer mTOR Inhibitors Consumption Comparison by Applications (2014-2025)
1.3.2 Breast Cancer
1.3.3 Hematological Malignancy
1.3.4 Neuroendocrine Tumors
1.3.5 Hepatocellular Carcinoma
1.3.6 Glioblastoma
1.4 Global Cancer mTOR Inhibitors Overall Market
1.4.1 Global Cancer mTOR Inhibitors Revenue (2014-2025)
1.4.2 Global Cancer mTOR Inhibitors Production (2014-2025)
1.4.3 North America Cancer mTOR Inhibitors Status and Prospect (2014-2025)
1.4.4 Europe Cancer mTOR Inhibitors Status and Prospect (2014-2025)
1.4.5 China Cancer mTOR Inhibitors Status and Prospect (2014-2025)
1.4.6 Japan Cancer mTOR Inhibitors Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cancer mTOR Inhibitors Status and Prospect (2014-2025)
1.4.8 India Cancer mTOR Inhibitors Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer mTOR Inhibitors
2.3 Manufacturing Process Analysis of Cancer mTOR Inhibitors
2.4 Industry Chain Structure of Cancer mTOR Inhibitors

3 Development and Manufacturing Plants Analysis of Cancer mTOR Inhibitors
3.1 Capacity and Commercial Production Date
3.2 Global Cancer mTOR Inhibitors Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cancer mTOR Inhibitors
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Cancer mTOR Inhibitors Production and Capacity Analysis
4.2 Cancer mTOR Inhibitors Revenue Analysis
4.3 Cancer mTOR Inhibitors Price Analysis
4.4 Market Concentration Degree

5 Cancer mTOR Inhibitors Regional Market Analysis
5.1 Cancer mTOR Inhibitors Production by Regions
5.1.1 Global Cancer mTOR Inhibitors Production by Regions
5.1.2 Global Cancer mTOR Inhibitors Revenue by Regions
5.2 Cancer mTOR Inhibitors Consumption by Regions
5.3 North America Cancer mTOR Inhibitors Market Analysis
5.3.1 North America Cancer mTOR Inhibitors Production
5.3.2 North America Cancer mTOR Inhibitors Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cancer mTOR Inhibitors Import and Export
5.4 Europe Cancer mTOR Inhibitors Market Analysis
5.4.1 Europe Cancer mTOR Inhibitors Production
5.4.2 Europe Cancer mTOR Inhibitors Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cancer mTOR Inhibitors Import and Export
5.5 China Cancer mTOR Inhibitors Market Analysis
5.5.1 China Cancer mTOR Inhibitors Production
5.5.2 China Cancer mTOR Inhibitors Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cancer mTOR Inhibitors Import and Export
5.6 Japan Cancer mTOR Inhibitors Market Analysis
5.6.1 Japan Cancer mTOR Inhibitors Production
5.6.2 Japan Cancer mTOR Inhibitors Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cancer mTOR Inhibitors Import and Export
5.7 Southeast Asia Cancer mTOR Inhibitors Market Analysis
5.7.1 Southeast Asia Cancer mTOR Inhibitors Production
5.7.2 Southeast Asia Cancer mTOR Inhibitors Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Cancer mTOR Inhibitors Import and Export
5.8 India Cancer mTOR Inhibitors Market Analysis
5.8.1 India Cancer mTOR Inhibitors Production
5.8.2 India Cancer mTOR Inhibitors Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Cancer mTOR Inhibitors Import and Export

6 Cancer mTOR Inhibitors Segment Market Analysis (by Type)
6.1 Global Cancer mTOR Inhibitors Production by Type
6.2 Global Cancer mTOR Inhibitors Revenue by Type
6.3 Cancer mTOR Inhibitors Price by Type

7 Cancer mTOR Inhibitors Segment Market Analysis (by Application)
7.1 Global Cancer mTOR Inhibitors Consumption by Application
7.2 Global Cancer mTOR Inhibitors Consumption Market Share by Application (2014-2019)

8 Cancer mTOR Inhibitors Major Manufacturers Analysis
8.1 Abraxis BioScience
8.1.1 Abraxis BioScience Cancer mTOR Inhibitors Production Sites and Area Served
8.1.2 Abraxis BioScience Product Introduction, Application and Specification
8.1.3 Abraxis BioScience Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Adimab
8.2.1 Adimab Cancer mTOR Inhibitors Production Sites and Area Served
8.2.2 Adimab Product Introduction, Application and Specification
8.2.3 Adimab Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Celgene Corporation
8.3.1 Celgene Corporation Cancer mTOR Inhibitors Production Sites and Area Served
8.3.2 Celgene Corporation Product Introduction, Application and Specification
8.3.3 Celgene Corporation Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celator Pharmaceuticals
8.4.1 Celator Pharmaceuticals Cancer mTOR Inhibitors Production Sites and Area Served
8.4.2 Celator Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Celator Pharmaceuticals Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eli Lilly
8.5.1 Eli Lilly Cancer mTOR Inhibitors Production Sites and Area Served
8.5.2 Eli Lilly Product Introduction, Application and Specification
8.5.3 Eli Lilly Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Exelixis
8.6.1 Exelixis Cancer mTOR Inhibitors Production Sites and Area Served
8.6.2 Exelixis Product Introduction, Application and Specification
8.6.3 Exelixis Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GlaxoSmithKline
8.7.1 GlaxoSmithKline Cancer mTOR Inhibitors Production Sites and Area Served
8.7.2 GlaxoSmithKline Product Introduction, Application and Specification
8.7.3 GlaxoSmithKline Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 HEC Pharm
8.8.1 HEC Pharm Cancer mTOR Inhibitors Production Sites and Area Served
8.8.2 HEC Pharm Product Introduction, Application and Specification
8.8.3 HEC Pharm Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Intellikine
8.9.1 Intellikine Cancer mTOR Inhibitors Production Sites and Area Served
8.9.2 Intellikine Product Introduction, Application and Specification
8.9.3 Intellikine Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Novartis
8.10.1 Novartis Cancer mTOR Inhibitors Production Sites and Area Served
8.10.2 Novartis Product Introduction, Application and Specification
8.10.3 Novartis Cancer mTOR Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Oneness Biotech
8.12 PIQUR Therapeutics
8.13 Semafore Pharmaceuticals
8.14 Takeda
8.15 Wyeth

9 Development Trend of Analysis of Cancer mTOR Inhibitors Market
9.1 Global Cancer mTOR Inhibitors Market Trend Analysis
9.1.1 Global Cancer mTOR Inhibitors Market Size (Volume and Value) Forecast 2019-2025
9.2 Cancer mTOR Inhibitors Regional Market Trend
9.2.1 North America Cancer mTOR Inhibitors Forecast 2019-2025
9.2.2 Europe Cancer mTOR Inhibitors Forecast 2019-2025
9.2.3 China Cancer mTOR Inhibitors Forecast 2019-2025
9.2.4 Japan Cancer mTOR Inhibitors Forecast 2019-2025
9.2.5 Southeast Asia Cancer mTOR Inhibitors Forecast 2019-2025
9.2.6 India Cancer mTOR Inhibitors Forecast 2019-2025
9.3 Cancer mTOR Inhibitors Market Trend (Product Type)
9.4 Cancer mTOR Inhibitors Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Cancer mTOR Inhibitors Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Cancer mTOR Inhibitors
Table Global Cancer mTOR Inhibitors Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Cancer mTOR Inhibitors Production Market Share by Types in 2018
Figure Afinitor/Votubia Product Picture
Figure Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Product Picture
Figure Torisel (Temsirolimus) Product Picture
Figure Evertor andndash Product Picture
Table Global Cancer mTOR Inhibitors Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Cancer mTOR Inhibitors Consumption Market Share by Applications in 2018
Figure Breast Cancer
Figure Hematological Malignancy
Figure Neuroendocrine Tumors
Figure Hepatocellular Carcinoma
Figure Glioblastoma
Figure Global Cancer mTOR Inhibitors Revenue (Million USD) (2014-2025)
Figure Global Cancer mTOR Inhibitors Production (K Pcs) (2014-2025)
Figure North America Cancer mTOR Inhibitors Market Size (Million USD) (2014-2025)
Figure Europe Cancer mTOR Inhibitors Market Size (Million USD) (2014-2025)
Figure China Cancer mTOR Inhibitors Market Size (Million USD) (2014-2025)
Figure Japan Cancer mTOR Inhibitors Market Size (Million USD) (2014-2025)
Figure Southeast Asia Cancer mTOR Inhibitors Market Size (Million USD) (2014-2025)
Figure India Cancer mTOR Inhibitors Market Size (Million USD) (2014-2025)
Table Cancer mTOR Inhibitors Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cancer mTOR Inhibitors in 2018
Figure Manufacturing Process Analysis of Cancer mTOR Inhibitors
Figure Industry Chain Structure of Cancer mTOR Inhibitors
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Cancer mTOR Inhibitors Manufacturing Plants Distribution
Table Cancer mTOR Inhibitors Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Cancer mTOR Inhibitors Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer mTOR Inhibitors Production (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer mTOR Inhibitors Production Market Share of Major Manufacturers (2014-2019)
Figure Cancer mTOR Inhibitors Production Share by Manufacturers in 2018
Table Cancer mTOR Inhibitors Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Cancer mTOR Inhibitors Revenue Market Share of Major Manufacturers (2014-2019)
Figure Cancer mTOR Inhibitors Revenue Share by Manufacturers in 2018
Table Cancer mTOR Inhibitors Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Cancer mTOR Inhibitors Production by Regions 2014-2019 (K Pcs)
Table Global Cancer mTOR Inhibitors Production Market Share by Regions 2014-2019
Figure Global Cancer mTOR Inhibitors Production Market Share by Regions in 2018
Table Global Cancer mTOR Inhibitors Revenue by Regions 2014-2019 (Million USD)
Table Global Cancer mTOR Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Cancer mTOR Inhibitors Revenue Market Share by Regions in 2018
Table Global Cancer mTOR Inhibitors Consumption by Regions 2014-2019 (K Pcs)
Table Global Cancer mTOR Inhibitors Consumption Market Share by Regions 2014-2019
Figure North America Cancer mTOR Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure North America Cancer mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table North America Cancer mTOR Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Europe Cancer mTOR Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Cancer mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Cancer mTOR Inhibitors Production, Consumption Import and Export (K Pcs)
Figure China Cancer mTOR Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure China Cancer mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table China Cancer mTOR Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Japan Cancer mTOR Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Cancer mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Cancer mTOR Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Cancer mTOR Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Cancer mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Cancer mTOR Inhibitors Production, Consumption Import and Export (K Pcs)
Figure India Cancer mTOR Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure India Cancer mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table India Cancer mTOR Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Cancer mTOR Inhibitors Market Share by Application (2014-2019)
Figure Global Value (Consumption) Cancer mTOR Inhibitors Market Share by Application (2014-2019)
Table Abraxis BioScience Cancer mTOR Inhibitors Production Sites and Area Served
Table Abraxis BioScience Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Abraxis BioScience Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abraxis BioScience Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Abraxis BioScience Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Abraxis BioScience Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Abraxis BioScience Cancer mTOR Inhibitors Main Business and Markets Served
Table Adimab Cancer mTOR Inhibitors Production Sites and Area Served
Table Adimab Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Adimab Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Adimab Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Adimab Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Adimab Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Adimab Cancer mTOR Inhibitors Main Business and Markets Served
Table Celgene Corporation Cancer mTOR Inhibitors Production Sites and Area Served
Table Celgene Corporation Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Celgene Corporation Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Corporation Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Celgene Corporation Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Celgene Corporation Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Celgene Corporation Cancer mTOR Inhibitors Main Business and Markets Served
Table Celator Pharmaceuticals Cancer mTOR Inhibitors Production Sites and Area Served
Table Celator Pharmaceuticals Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Celator Pharmaceuticals Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celator Pharmaceuticals Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Celator Pharmaceuticals Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Celator Pharmaceuticals Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Celator Pharmaceuticals Cancer mTOR Inhibitors Main Business and Markets Served
Table Eli Lilly Cancer mTOR Inhibitors Production Sites and Area Served
Table Eli Lilly Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Eli Lilly Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Eli Lilly Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Eli Lilly Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Eli Lilly Cancer mTOR Inhibitors Main Business and Markets Served
Table Exelixis Cancer mTOR Inhibitors Production Sites and Area Served
Table Exelixis Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Exelixis Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Exelixis Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Exelixis Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Exelixis Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Exelixis Cancer mTOR Inhibitors Main Business and Markets Served
Table GlaxoSmithKline Cancer mTOR Inhibitors Production Sites and Area Served
Table GlaxoSmithKline Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table GlaxoSmithKline Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table GlaxoSmithKline Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure GlaxoSmithKline Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table GlaxoSmithKline Cancer mTOR Inhibitors Main Business and Markets Served
Table HEC Pharm Cancer mTOR Inhibitors Production Sites and Area Served
Table HEC Pharm Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table HEC Pharm Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table HEC Pharm Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table HEC Pharm Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure HEC Pharm Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table HEC Pharm Cancer mTOR Inhibitors Main Business and Markets Served
Table Intellikine Cancer mTOR Inhibitors Production Sites and Area Served
Table Intellikine Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Intellikine Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Intellikine Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Intellikine Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Intellikine Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Intellikine Cancer mTOR Inhibitors Main Business and Markets Served
Table Novartis Cancer mTOR Inhibitors Production Sites and Area Served
Table Novartis Cancer mTOR Inhibitors Product Introduction, Application and Specification
Table Novartis Cancer mTOR Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Cancer mTOR Inhibitors Production Growth Rate (2014-2019)
Table Novartis Cancer mTOR Inhibitors Production Market Share (2014-2019)
Figure Novartis Cancer mTOR Inhibitors Revenue Market Share (2014-2019)
Table Novartis Cancer mTOR Inhibitors Main Business and Markets Served
Table Oneness Biotech Cancer mTOR Inhibitors Production Sites and Area Served
Table PIQUR Therapeutics Cancer mTOR Inhibitors Production Sites and Area Served
Table Semafore Pharmaceuticals Cancer mTOR Inhibitors Production Sites and Area Served
Table Takeda Cancer mTOR Inhibitors Production Sites and Area Served
Table Wyeth Cancer mTOR Inhibitors Production Sites and Area Served
Figure Global Cancer mTOR Inhibitors Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Cancer mTOR Inhibitors Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Cancer mTOR Inhibitors Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Cancer mTOR Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Cancer mTOR Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Cancer mTOR Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Cancer mTOR Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Cancer mTOR Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Cancer mTOR Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Cancer mTOR Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Cancer mTOR Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Cancer mTOR Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Cancer mTOR Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Cancer mTOR Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Cancer mTOR Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Cancer mTOR Inhibitors by Type (2019-2025)
Table Global Consumption (K Pcs) of Cancer mTOR Inhibitors by Application (2019-2025)
Table Cancer mTOR Inhibitors Distributors List
Table Cancer mTOR Inhibitors Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abraxis BioScience、Adimab、Celgene Corporation、Celator Pharmaceuticals、Eli Lilly、Exelixis、GlaxoSmithKline、HEC Pharm、Intellikine、Novartis、Oneness Biotech、PIQUR Therapeutics、Semafore Pharmaceuticals、Takeda、Wyeth、

★調査レポート[世界のがんmTOR阻害剤市場 2019年] (コード：DATA909X04992)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがんmTOR阻害剤市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のがんCDK阻害剤市場 2019年
    DATA909X04989 / QYResearch / 2019年11月15日 / ※本調査レポートは、がんCDK阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、前臨床、フェーズI、フェーズI / II、フェーズII、フェーズIIIに、用途別には、病院、診療所、その他にセグメント区分し、がんCDK阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・がんCDK阻害剤の世界市場概要 ・がんCDK阻害剤の製造コスト構成分析 ・がんCDK阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・がんCDK阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド）...The global Cancer CDK Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer CDK Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer CDK Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cancer CDK Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のがんチューブリン阻害剤市場 2019年
    DATA909X04995 / QYResearch / 2019年11月15日 / ※本調査レポートは、がんチューブリン阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ドセタキセル、トラスツズマブエムタンシン、アブラキサン、ブレンツキシマブベドチン、カバジタキセルに、用途別には、非小細胞肺がん、前立腺がん、乳がん、大腸がん、卵巣がんにセグメント区分し、がんチューブリン阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・がんチューブリン阻害剤の世界市場概要 ・がんチューブリン阻害剤の製造コスト構成分析 ・がんチューブリン阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・がんチューブリン阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・がんチューブリン阻害剤のセグメント分析（種類別） （ドセタキセル、トラスツズマブエムタンシン、アブラキサン、ブレンツキシマブベドチン、カバジタキセル）...The global Cancer Tubulin Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Tubulin Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Tubulin Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Tubulin Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の非チロシンキナーゼ阻害剤市場 2019年
    DATA909X12094 / QYResearch / 2019年11月20日 / ※本調査レポートは、非チロシンキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、mTOR阻害剤、RAF / MEK阻害剤、CDK阻害剤に、用途別には、肝臓がん、呼吸器がん、脳がん、その他にセグメント区分し、非チロシンキナーゼ阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・非チロシンキナーゼ阻害剤の世界市場概要 ・非チロシンキナーゼ阻害剤の製造コスト構成分析 ・非チロシンキナーゼ阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・非チロシンキナーゼ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド）...The global Non-Tyrosine Kinase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non-Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-Tyrosine Kinase Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Non-Tyrosine Kinase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のヒストン脱アセチル化酵素阻害剤市場 2019年
    DATA909X09205 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒストン脱アセチル化酵素阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、競合阻害剤、非競合阻害剤、混合阻害剤に、用途別には、精神神経学、癌治療、炎症性疾患、その他疾患にセグメント区分し、ヒストン脱アセチル化酵素阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒストン脱アセチル化酵素阻害剤の世界市場概要 ・ヒストン脱アセチル化酵素阻害剤の製造コスト構成分析 ・ヒストン脱アセチル化酵素阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒストン脱アセチル化酵素阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒストン脱アセチル化酵素阻害剤のセグメント分析（種類別） （競合阻害剤、非競合阻害剤、混合阻害剤）...The global Histone Deacetylase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Histone Deacetylase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Histone Deacetylase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X18797 / QYResearch / 2019年11月25日 / ※当調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場について調査・分析し、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（オラパリブ、タラゾパリブ）、用途別（卵巣がん、乳がん、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場動向 ・主要企業別マーケットシェア ・PARP（ポリADPリボースポリメラーゼ）阻害剤の種類別市場規模2014-2019 （オラパリブ、タラゾパリブ） ・PARP（ポリADPリボースポリメラーゼ）阻害剤の用途別市場規模2014-2019 （卵巣がん、乳がん、その他） ・PARP（ポリADPリボースポリメラーゼ）阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・PARP（ポリADPリボースポリメラーゼ）阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoting apoptosis of tumor cells. Parp (Poly Adp-Ribose Polymerase) inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer, fallopian tube cancer and primary peritoneal cancer.In 2018, the global PARP (Poly ADP-ribose Polymerase) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR...
  • 世界のヒストン脱アセチル化酵素（HDAC）阻害剤市場 2019年
    DATA909X09206 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒストン脱アセチル化酵素（HDAC）阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヒドロキサム酸、環状テトラペプチド、ベンズアミド、求電子ケトン、脂肪族酸に、用途別には、精神神経学、癌治療、HIV、その他にセグメント区分し、ヒストン脱アセチル化酵素（HDAC）阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒストン脱アセチル化酵素（HDAC）阻害剤の世界市場概要 ・ヒストン脱アセチル化酵素（HDAC）阻害剤の製造コスト構成分析 ・ヒストン脱アセチル化酵素（HDAC）阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒストン脱アセチル化酵素（HDAC）阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒストン脱アセチル化酵素（HDAC）阻害剤のセグメント分析（種類別） （ヒドロキサム酸、環状テトラペプチド、ベンズアミド、求電子ケトン、脂肪族酸）...The global Histone Deacetylase(HDAC) Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Histone Deacetylase(HDAC) Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase(HDAC) Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Histone Deacetylase(HDAC) Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆